HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Differential effects of paclitaxel and docetaxel on gap junctions affects their cytotoxicities in transfected HeLa cells.

Abstract
Gap junctions (GJs) enhance the cytotoxicity of specific cancer chemotherapeutic drugs and therefore, the inhibition of functional GJs may represent a mechanism by which the toxicity of chemotherapeutics in cancer cells can be reduced. In the present study, the effects and mechanisms of paclitaxel and docetaxel on GJ intercellular communication (GJIC) and the modulation of drug cytotoxicity were investigated in HeLa cells that were stably transfected with the connexin (Cx) 32 expression plasmid. Paclitaxel, but not docetaxel, was observed to inhibit dye‑coupling through junctional channels. Gating closure rather than the alteration of Cx32 expression or its membrane localization was responsible for the inhibitory action of paclitaxel on GJ function following short‑term exposure. The results revealed that the cytotoxicity of paclitaxel or docetaxel increased in the presence of functional GJs compared with that observed when GJIC was suppressed. In addition, paclitaxel‑induced downregulation of GJIC decreased the cytotoxicity of paclitaxel in the presence of functional GJs compared with that of docetaxel, which did not affect Cx32 channels. These observations demonstrated that the differential effects of paclitaxel and docetaxel on GJIC may affect the cytotoxicity of chemotherapeutic drugs. The present study provides a promising new approach to select antineoplastics and improve drug efficacy in carcinoma cells that form GJs.
AuthorsNan Tang, Qin Wang, Dengpan Wu, Suzhi Zhang, Yuan Zhang, Liang Tao
JournalMolecular medicine reports (Mol Med Rep) Vol. 8 Issue 2 Pg. 638-44 (Aug 2013) ISSN: 1791-3004 [Electronic] Greece
PMID23799576 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents, Phytogenic
  • Connexins
  • Taxoids
  • connexin 32
  • Docetaxel
  • Paclitaxel
Topics
  • Antineoplastic Agents, Phytogenic (pharmacology)
  • Cell Survival (drug effects)
  • Connexins (genetics, metabolism)
  • Docetaxel
  • Dose-Response Relationship, Drug
  • Gap Junctions (drug effects)
  • Gene Expression
  • HeLa Cells
  • Humans
  • Paclitaxel (chemistry, pharmacology, toxicity)
  • Taxoids (chemistry, pharmacology, toxicity)
  • Transfection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: